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Abstract
Sleep disordered breathing (SDB) during pregnancy covers a diverse 
spectrum of pathological conditions provoked by physiological 
changes in maternal organism and growing fetus. Most of the symp�
toms (sleepiness, fatigue, vomiting, snoring, obstructed nasal breath�
ing, etc.) are considered to be „normally“-related to the physiologi�
cal changes during pregnancy. In fact, that subtle complains could 
be a harbinger of more complex disorders, which could remain 
neglected and undiagnosed by the consulting obstetric and gynecol�
ogy specialist or primary physician. In view of the potential serious 
complications related to the SDB during pregnancy it is essential 
to consider even the mild complains of the pregnant woman as 
prospective alarming symptoms. Interdisciplinary consultation with 
otorhinolaryngologist and subsequent detailed polysomnographic 
study are essential for proper diagnosis in order to avoid possible life 
threatening complications.
Introduction 
There is a lot of “confusing” specialized terminol�
ogy associated with sleep disordered breathing 
applicable in the daily routine clinical practice of 
the otorhinolaryngologists1. According to the sec�
ond international classification of sleep disorders 
(ICSD II), based on the strict clinical observations 
and prйcised diagnostic criteria, SDB is consid�
ered to be a descriptive term for wide range of 
clinical pathology – simple (habitual) snoring, 
upper respiratory resistance syndrome (URRS), 
obstructive sleep apnea (OSA), central sleep apnea 
(CSA) and obesity-related hypoventilation syn�
drome (OHS)2. Apnea is described as a complete 
restriction or ≥ 90% obstruction of the airflow for 
minimum period of 10 seconds, which is usually 
associated with reduction of blood oxygen concen�
tration (desaturation) and sleep fragmentation with 
abrupt change of brain activity from deep sleep to 
wakefulness (arousals). Hypopnea is presumably 
less severe condition than apnea and is caused 
by partial obstruction of the airway. Hypopnea is 
controversially defined as a different flow limita�
tion during sleep (≥ 30% or ≥ 40%) which last at 
least 10 seconds and are associated with varying 
desaturation rate (≥ 4% or ≥ 3% respectively). 
AHI is the average number of apnea and hypopnea 
episodes for a period of 1 hour during sleep. Respi�
ratory effort�related arousals (RERA) – arousals 
observed when increased respiratory efforts are 
generated during sleep for more than 10 seconds 
as an outcome of elevated resistance of the upper 
respiratory tract (URT). Cessation of breathing last 
shorter, don’t meet the criteria for hypopnea and 
apnea, results in transition from the deeper to more 
superficial sleep stage and disappear subsequently. 
Usually RERA are ironically called “wannabe 
hypopnea” and are measured by nasal cannula 
with pressure transducer, pneumotachograph or 
esophageal manometry during polysomnography 
(PSG)3. Reparatory distress index (RDI) stands for 
the sum up of all pathologically registered breath�
ing disturbances – RERA, apnea and hypopnea 
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for one hour and represent more precise predictive 
criterion for the gravity of sleep�related disorders. 
Nevertheless the simple snoring is generally con�
sidered as an annoying disturbance, it could be 
early and alarming symptom of obstructive sleep 
apnea, requiring full medical attention. Habitual 
snoring is not pathophysiologically associated with 
flow limitations, desaturations or arousals dur�
ing sleep. The difference between typical clinical 
presentation of moderate to severe URRS and 
OSA in adult patients slightly differs and could be 
validated by ENT�specialist on the basis of clinical 
examination and PSG sleep characteristics as sum�
marized in Table 1.
Table 1. Differences in clinical presentation and sleep characteristics �etween URRS and OSA.
Clinical presentation URRS OSA
age younger 40 – 60 years old
female : male ratio 1:2 1:8
�ody weight non-o�ese o�ese
sleepiness fatigue excessive day-time sleepiness
�lood pressure hypotension (orthostatic) hypertension




(sleep walking, sleep terror)
short sleep onset
desaturation not significant significant
sleep fragmentation AHI < 5 AHI ≥ 15
RERA ≥10 5-10
Obstructive sleep apnea is defined as a desaturation 
rate bigger than 4% from the baseline in awaken 
condition and minimum 50% decrease on airflow 
or complete stop of breathing for at least 10 seconds 
during sleep. The exact frequency of OSA among 
pregnant woman is not statistically proven by meta�
analysis, but it is approximately estimated that 
about 6 % of reproductive female population could 
be affected4. The main reason for this inaccuracy is 
that the clinical assessment is based predominantly 
on the questionnaire survey and usually the results 
are not confirmed by PSG. 
„Hormonal storm“ and pathophysiological 
changes
Normal pregnancy is usually related to the series 
of biochemical and hormonal changes during the 
first and second trimester of pregnancy, while 
the mechanical changes (progressive weight gain, 
upward displacement of the diaphragm) are asso�
ciated with the growing fetus inside the maternal 
organism, could affect significantly the sleep�
ing patterns during the third trimester. Estrogen 
and progesterone levels are noticeably elevated 
during pregnancy and could provoke physiologi�
cal changes with pathological outcome. Estrogen 
induces hyperemia and edema of the nasopha�
ryngeal mucosa5, which result in increased upper 
respiratory tract resistance. During pregnancy the 
nasal patency could be obstructed mainly by the 
physiological actions of different hormones – pla�
cental trophoblastic hormone (hypertrophy of the 
nasal mucosa)6, progesterone (local vasodilatation 
and increased blood flow) and estrogen (increased 
histamine receptors on the nasal epithelial cells 
and endothelial cells with subsequent stimula�
tion of the neo-microvascularisation)7. Increased 
resistance of upper respiratory tract in a combina�
tion with physiological hypervolemia in pregnant 
women could amplify significantly the risk of SDB 
during pregnancy, which is more pronounced in 
the third trimester8. Estrogen disrupts significantly 
the sleep architecture by inhibiting REM sleep9. 
Progesterone is produced mainly by the placental 
tissue at the moment of implantation and overrides 
the effect of other hormones during the first trimes�
ter. It is considered that progesterone exerts strong 
sedative effect resulting in increased total sleep 
time and decreased sleep latency10. On the other 
hand, progesterone has a stimulating effect over the 
sensitivity of respiratory center towards CO2 and 
thus stimulates respiration11. Physiological levels 
of cortisol start progressively to increase from 25th 
to 28th gestational week and rapidly normalize after 
delivery. The pathophysiological effect of the cor�
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tisol is probably related to reduction of REM sleep 
duration throughout the prenancy12. Functional 
residual capacity (FRC) of the lungs is decreased 
by upward displacement of the diaphragm during 
the third trimester, which is supplementary to the 
physiological reduction of FRC during sleep13. The 
described pathophysiological changes are associ�
ated with diminished maternal oxygenation14 as 
well as increased collapsibility of the pharynx15.
Clinical considerations and complications
Pregnancy-related SDB could be demonstrated in 
the wide range of symptoms during sleep in the 
clinical spectrum from habitual snoring to obe�
sity�related hypoventilation syndrome, which is 
arguably considered as the most severe form of 
the disease in pregnant women16. Snoring is very 
common clinical finding among pregnant women 
and the prevalence is estimated about 14%, which 
is significantly higher in comparison with the inci�
dence in non-pregnant female population (approxi�
mately 4%)17. Furthermore snoring is a nonspecific 
clinical observation and usually starts at the end of 
the second trimester. In the same time snoring is the 
most frequent complaint of OSA during pregnancy, 
especially in obese women. Gestational rhinitis 
(GR) is a pathological condition which differs sig�
nificantly from the more familiar and popular entity 
rhinitis during pregnancy (RPr). RPr encompass 
all types of rhinitis, which could possibly appear 
before, during and after pregnancy, regardless of 
the etiology (inflammatory, allergic, non-allergic, 
drug induced, vasomotor and etc.). GR typically 
emerges during pregnancy in the second or third 
trimester, lasts at least 6 weeks or longer and disap�
pears about 2 weeks postpartum18. GR is not associ�
ated with allergic or inflammatory conditions and 
usually is attributed to the hormonal changes. On 
the basis of clinical signs and questionnaire survey 
the prevalence of GR is estimated about 9 % at 
the time of delivery19. Obstructed nasal breathing, 
rhinorrhea and impaired quality of life are not the 
only outcomes of GR. Worsening of the sleep qual�
ity, snoring and gravity of apnea of the childbearing 
woman with OSA could be attributed to the GR, 
especially in those clinical cases associated with 
overweight during pregnancy20. Furthermore, oral 
breathing as a result form nasal obstruction leads to 
decrease in nitric oxide (NO) inhalation in the lungs 
with further negative effect on the maternal blood 
pressure, preeclampsia, retarded intrauterine fetus 
growth, lower Apgar score of the newborn and etc.21 
Recently an attempt has been made to establish the 
exact prevalence of obstructive sleep apnea among 
pregnant women overcoming the imperfections of 
the traditional screening tools and has been validat�
ed that the occurrence is about 4.9%22. OSA is char�
acterized by repeated cessation of the respiratory 
airflow, accompanied by oxygen desaturation and 
arousals. Significant reduction of nocturnal satura�
tion of the peripheral blood during the third trimes�
ter of pregnancy has been reported in comparison 
with the results of the postpartum PSG studies of 
the same subjects23. Recurring episodes of respira�
tory obstruction during sleep could lead to maternal 
hypoxemia. Hypoxemia during sleep has been 
established both in normotensive and hypetrten�
sive pregnancies around the third trimester24. It 
has been speculated that SDB-related intermittent 
hypoxia could in turn provoke oxidative stress and 
endothelial activation25, which are major factors in 
development of pregnancy�induced hypertension26. 
Maternal complications such as hypertension and 
preeclampsia are frequently reported to be related 
to OSA during pregnancy and generally have been 
characterized by the absence of nocturnal dipping 
in systolic blood pressure27, 28. Mild sleep�induced 
inspiratory flow limitations were detected during 
the polysomnography in preeclamptic women and 
subsequently disappear after continuous positive 
airway pressure therapy. This process is accompa�
nied by normalization of the blood pressure, dem�
onstrating a possible causative connection between 
OSA and hypertension29. The described minor 
inspiratory flow limitations couldn’t be classified as 
apnea or hypopnea and typically are not associated 
with arousals. As a negative outcome in pregnant 
women with OSA has been also described gesta�
tional diabetes30. Clinical course of maternal OSA 
is frequently related to hypertension and periph�
eral vasoconstriction, which could possibly play a 
role in reduction of placental flow and subsequent 
harmful for the fetus. It has been proven by clini�
cal survey with questionnaires and subsequently 
validated through PSG that even the mild OSA 
cases could contribute for the fetus growth retar�
dation and increased risk of stillbirth in the late 
pregnancy31. On the other hand, increased number 
of pathologic conditions in the postnatal period is 
attributed to the OSA during pregnancy – low birth 
weight, small for gestation age infant, preterm birth 
and low Apgar scores32. 
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Diagnostic approach 
Questionnaires are very effective tool for screening 
purposes and early detection of the subtle precur�
sors indicative for OSA during pregnancy such as: 
sleepiness, fatigue, snoring, witnessed apneic epi�
sodes and etc. Daytime sleepiness associated with 
pregnancy is considered to be normal clinical obser�
vation and taking into account the natural women 
hesitation to complain about snoring, gasping and 
other “uncomfortable” topics, frequently leads 
to significant delay of OSA diagnosis. Epworth 
Sleepiness Scale (ESS) has been routinely used for 
assessment of the degree of daytime sleepiness and 
probability to fall asleep in different situations. The 
maximal test score is 26 and the results ≥ 10 are 
with increased risk for OSA. It has to be mentioned 
that sleepiness is not very specific for OSA during 
pregnancy because of the regular daytime nap or 
subjective interpretation of the symptom rather as 
a fatigue, “unrefreshed” condition or tiredness than 
sleepiness. Additionally, sleepiness could not be 
typically observed in pregnant and preeclamtptic 
women33 which requires supplementary screening 
tools for objective and prйcised evaluation such 
as multiple sleep latency test (MSLT). MSLT was 
originally proposed as a diagnostic tool for narco�
lepsy which evaluates the degree of sleepiness and 
how fast the patient falls asleep. MSLT is a full day 
test, which consists of 5 scheduled naps throughout 
the day separated by 2 hours intervals. The com�
bination of ESS and MSLT could be an effective 
tool for early detection of OSA during pregnancy. 
The quality of sleep and sleep disordered breath�
ing are effectively evaluated by another symp�
tom based screening questionnaire, called Berlin 
questionnaire (BQ)34. BQ consists of 10 questions 
subdivided in 3 groups – snoring, sleepiness and 
body weight (plus chronic hypertension) and the 
effectiveness of clinical application of BQ for 
early OSA diagnosis in non�pregnant population 
has been estimated at up to 86% sensitivity and 
95% specificity35. Controversially the high�score 
results from BQ in pregnant women are not reliable 
predictors for OSA, especially in those risk groups 
related to obesity36.
ENT consultation is major diagnostic approach for 
establishing the presence and gravity of increased 
upper respiratory tract resistance during pregnancy. 
Anterior rhinoscopy is valuable and informative 
method which determines the level of obstruction 
(nasal septum deviation, hypertrophy of the infe�
rior turbinate, etc). The most important anatomical 
sites, which could generate significant obstruction 
in the upper respiratory tract, lay at the level of the 
nasal valve and glottis area. Nasal segment of the 
URT is capable of creating almost 5-6 times higher 
resistance than the pharyngeal segment37. Nasal 
endoscopy is effective method for discovering of 
co-morbid pathology (sinusitis, nasal polyposis) 
which could contribute to increase URT resistance. 
Mьller’s maneuver (MM) is easy to perform yet 
informative tool for fast evaluation of collapsibility 
of the retropalatal and retroglossal areas in awaken 
condition. Regardless the inconsistencies of result 
interpretation and relatively low predictive value 
for development of OSA, MM is still applicable 
in daily routine practice of otorhinolaryngologists 
for determining the level of obstruction. Originally 
developed for assessment of anatomical difficulties 
created by the palatal tonsil and the tongue during 
endotracheal intubation, the Mallampati score is 
easy to calculate and to determine the degree of 
pharyngeal edema accompanying different periods 
of pregnancy (mainly 12 and 38 gestation week) as 
a prerequisite of increased URT resistance38. 
Polysomnography is the golden standard for diag�
nosis of obstructive sleep apnea during pregnancy. 
Generally PSG study of pregnant women could be 
conducted in the same manner as in non�pregnant 
women, without any concern about possible con�
traindications39. It should be taken into consider�
ation that generally pregnant women prefer to lay 
in bed in lateral position, which could affect the 
prйcised registration of AHI score. PSG study is 
recommended not only in cases with severe com�
plications (gestational hypertension, gestational 
diabetes preeclampsia, intrauterine growth retar�
dation of the fetus, etc.) and clinical cases with 
obesity�complicated pregnancies40. The evaluation 
of specific diagnostic criteria such as: inspiratory 
flow limitations (IFL) and RDI required overnight 
full PSG study using nasal cannula with pressure 
transducer and termistor, which is not possible in 
conventional polygraphy used predominantly for 
screening purposes40. Determining IFL is essential 
step in precise diagnosis of abnormal respiratory 
events in preeclamptic women, which are generally 
not associated with apneic episodes and are detect�
ed during the abnormal rise of blood pressure41.
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Treatment strategies 
Symptomatic conservative treatment is defined 
by the application of different medication which 
doesn’t have curative effect, but rather temporally 
relive of the clinical complaints. The general pro�
phylactic measures42 (elevated > 30° position of the 
head during sleep, sleeping on a lateral position, 
physical exercises, weight control, improving sleep 
hygiene, avoiding alcohol and sedatives, etc.)43 and 
topical application of saline solutions (especially 
hypertonic) could be beneficial for the save and tem�
porally relieve of GR symptoms18. Pregnant women 
with GR are frequently obsessed with the usage of 
topical decongestants for a prolonged period of time. 
The inadequate usage (longer than 5 days, applica�
tion during the 1st trimester or close to delivery term 
as well as inappropriate higher dosage) of α-mimet�
ics (phenylephrine, naphazoline, oxymetazoline and 
xylometazoline) leads to tachyphylaxis and negative 
effect on the nasal mucosa (drug-associated rhinitis), 
increased contractility of the uterus (preterm birth) 
plus possible congenital defects (pyloric steno�
sis, renal abnormalities)44. Systemic decongestants 
(pseudoephedrine, phenylpropanolamine) taken 
especially during the 1st trimester of pregnancy are 
associated with life threatening conditions such as: 
gastroschisis, endocardial wall closure defects and 
external ear malformations45. Considering the negli�
gible clinical improvement of the natural course of 
GR and possible teratogenic effects of wide range of 
drugs (local and systemic corticosteroids, antihista�
mines, anti-leukotrienes inhibitors) it is not recom�
mended to be used as a treatment strategy in co�mor�
bid allergic rhinitis during pregnancy. In those cases 
it is more appropriate to use sodium cromoglycate or 
topical ipratropium bromide to cope with the severe 
rhinorrhea of moderate to severe allergic rhinitis 
during pregnancy18. 
Oral appliances are effective in reduction of upper 
respiratory tract resistance by pulling forwards 
genioglossus muscle, expanding pharyngeal antero�
posterior dimensions. Dental appliances usually 
find application for treatment of habitual snoring 
and mild to moderate OSA. As a major drawback of 
mandibular advancement devices could be pointed 
out a relatively long period of time necessary for 
fabrication and adjustment (titrating) according to 
individual needs of the patient46. 
Positive airway pressure (PAP) is a gold stan�
dard for conservative treatment of OSA during 
pregnancy. Continuous positive airway pressure 
(CPAP) therapy is safe, generally well-tolerated 
and effective treatment with significant outcomes 
both for the mother (overcome apneic episodes, 
improves flow limitations, increase nocturnal oxy�
genation, reduce arterial pressure, etc.) and the 
fetus (improved fetal movements, change in move�
ment patterns, reduced fetal hiccups) especially in 
preeclamptic patients47. The application of CPAP 
therapy during pregnancy is recommended for mild 
to moderate (AHI, 5-30/hour) and severe (AHI, > 
30/hour) OSA cases associated with desaturation 
level ≤ 90%48. CPAP therapy during pregnancy is 
consistent with very good compliance level39, even 
in cases when OSA is combined with preeclampsia 
as co�morbidity49. The usage of nasal CPAP dur�
ing pregnancy is not associated with any adverse 
effects50 and usually is terminated 2 weeks after 
delivery. The main target of CPAP therapy is to 
achieve favorable improvement of the saturation 
level (> 90%) and to acquire RDI level < 5 per 
hour during sleep48. Pregnant women diagnosed 
before or in the beginning of the pregnancy with 
SDB usually required recalibration of the CPAP 
equipment around the 6 month49. In severe cases 
associated with obesity�related OSA pregnancies 
or multiple gestations (twin pregnancies) is more 
favorable to use bi�level positive airway pressure 
(BiPAP) instead of CPAP ventilation. In order to 
improve the effectiveness of PAP treatment it is 
recommended to combine the artificial ventilation 
with supplementary oxygen therapy (OXT). OXT 
is not recommended as a primary treatment of OSA 
during pregnancy because of the potential risk of 
prolonged episodes of apnea, raised level of carbon 
dioxide in the circulating peripheral blood (hyper�
capnia) and increased ventricular irritability51.
Surgery is limited only for the most severe cases of 
OSA uninfluenced by the conservative treatment, 
patients with low compliance rate toward CPAP 
therapy or those clinical cases posing high�grade risk 
of serious complications for the pregnant woman 
and her baby. In cases with severe OSA secondary 
to GR and refractory to conservative treatment could 
be recommended a volume reduction of the inferior 
turbinate18. Considering the increased surgical risk 
and inconsistent long�term results performing a 
conventional uvulopalatopharyngoplasty (UVPP)52 
is not recommended for treatment of OSA during 
pregnancy53. There is just one case in the literature 
reporting benefits from tracheostomy in a pregnant 
woman with obstructive sleep apnea 54. 
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